The Scientist

» gene patents and ecology

Most Recent

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Beach Reading

Beach Reading

By | July 1, 2013

A vacation from your lab doesn’t have to mean a break from fascinating developments on the life science front.

0 Comments

image: Contributors

Contributors

By | July 1, 2013

Meet some of the people featured in the July 2013 issue of The Scientist.

0 Comments

image: Research Behind Bars

Research Behind Bars

By | July 1, 2013

Ecologist Nalini Nadkarni advances forest conservation and science advocacy by enlisting the help of prisoners.

0 Comments

image: Science on Lockdown

Science on Lockdown

By | July 1, 2013

A forest ecologist comes down from the canopy to bring science to the masses, forming a series of improbable collaborations with prisoners.

3 Comments

image: Sea Bugs

Sea Bugs

By | July 1, 2013

Ocean viruses can impact marine ecosystems in several ways.

0 Comments

image: An Ocean of Viruses

An Ocean of Viruses

By | July 1, 2013

Viruses abound in the world’s oceans, yet researchers are only beginning to understand how they affect life and chemistry from the water’s surface to the sea floor.

3 Comments

image: Week in Review, June 17–21

Week in Review, June 17–21

By | June 21, 2013

On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity

0 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

image: Opinion: On Patenting Genes

Opinion: On Patenting Genes

By | June 18, 2013

The scientific community and the impact of the Myriad Genetics Supreme Court decision

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS